Development of a quality of life questionnaire for transgender individuals during hormone therapy (iTransQol).
Gender affirming hormone therapy
Quality of life
Questionnaire
Transgender
Journal
Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
16
02
2022
accepted:
22
06
2022
pubmed:
26
7
2022
medline:
16
9
2022
entrez:
25
7
2022
Statut:
ppublish
Résumé
Quality of life (QoL) is a complex term, including mental, physical and social health, and everyone's individual environment. While transgender individuals still often report lower QoL than other individuals, they can benefit substantially from gender affirming therapy. The aim of this study was to develop a questionnaire to determine QoL in transgender individuals during gender affirming hormone therapy (GAHT). A multi-step questionnaire development process was performed. In phase 1, a list of key issues was established by reviewing relevant literature. In phase 2, n = 38 transgender individuals as well as n = 6 practitioners evaluated the questionnaire (iTransQoL) in terms of relevance, meaning, comprehensibility and redundancy. Psychometric testing of the questionnaire was performed in phase 3 with n = 40 transgender individuals. The external validity of the iTransQoL was tested by comparison with three validated health questionnaires. The exploratory factor analysis indicated an underlying four-factor solution. Psychometric testing showed acceptable to good overall reliability (α = 0.73-0.83) for the total score and the four subscales as well as good validity indices. Based on the results, a final version of the iTransQoL was established. The iTransQoL is a reliable and valid tool to evaluate QoL of transgender individuals during GAHT.
Identifiants
pubmed: 35876907
doi: 10.1007/s00404-022-06689-9
pii: 10.1007/s00404-022-06689-9
pmc: PMC9470628
doi:
Substances chimiques
Hormones
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1337-1347Informations de copyright
© 2022. The Author(s).
Références
Int J Transgend. 2019 Jun 27;20(2-3):251-262
pubmed: 32999611
Health Qual Life Outcomes. 2018 Aug 20;16(1):167
pubmed: 30126432
Qual Life Res. 2004 Mar;13(2):299-310
pubmed: 15085902
Qual Life Res. 2006 Nov;15(9):1447-57
pubmed: 16758113
Lancet. 2016 Jul 23;388(10042):412-436
pubmed: 27323919
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Z Psychosom Med Psychother. 2014;60(1):3-16
pubmed: 24615234
Qual Life Res. 1993 Apr;2(2):153-9
pubmed: 8518769
Med Care. 2008 Mar;46(3):266-74
pubmed: 18388841
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
LGBT Health. 2019 Jan;6(1):34-39
pubmed: 30562128
Rev Endocr Metab Disord. 2018 Sep;19(3):199-220
pubmed: 30121881
Int J Transgend. 2018 May 25;20(2-3):289-304
pubmed: 32999614
J Am Acad Child Adolesc Psychiatry. 1997 Feb;36(2):263-71
pubmed: 9031580
Bull World Health Organ. 2002;80(12):981-4
pubmed: 12571728
J Clin Endocrinol Metab. 2017 Nov 1;102(11):3869-3903
pubmed: 28945902
Int J Transgend Health. 2020 Apr 11;21(2):194-208
pubmed: 33015669
LGBT Health. 2021 Nov;8(8):536-544
pubmed: 34648726
Am J Public Health. 2013 May;103(5):943-51
pubmed: 23488522
Int J Transgend. 2018 Apr 26;20(1):63-80
pubmed: 32999594